Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people with knowledge of the matter said. The drugmakers, which both emerged ...

Bengaluru: Mallinckrodt and Endo , drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued at nearly $7 billion to boost scale for selling their ...

While Mallinckrodt emerged from its second bankruptcy in November 2023, Endo returned last year. The drugmakers are discussing the terms of a transaction that would give each of them roughly 50% ...

Mallinckrodt and Endo (NDOI.PK), opens new tab, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at ...

(Reuters) -Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at $6.7 billion.

Mallinckrodt and Endo, drugmakers with a shared history of facing bankruptcy and US opioid litigation, have agreed to merge in a deal valued at nearly $7 billion. Endo shareholders will get $80m ...

Mallinckrodt and Endo, drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued at nearly $7 billion to boost scale for selling their branded drugs. Endo ...

Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. A deal could likely be announced as soon as ...